Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
A case of primary ovarian adenomyoma mimicking ovarian malignancy.
Kim JO, Baek JM, Jeung C, Park EK, Lee HN, Lee YS.
Eur J Gynaecol Oncol. 2011;32(1):103-6. Review.
Related citations
Leptin receptor expression in neoplastic and normal ovarian and endometrial tissue.
Mantzos F, Vanakara P, Samara S, Wozniak G, Kollia P, Messinis I, Hatzitheofilou C.
Eur J Gynaecol Oncol. 2011;32(1):84-6. Erratum in: Eur J Gynaecol Oncol. 2011;32(2):132. Wosniak, G [corrected to Wozniak, G].
Clinical analysis of borderline ovarian tumors.
Ha JE, Jeung IC, Lee YS, Lee HN, Park EK.
Eur J Gynaecol Oncol. 2011;32(1):69-72.
Role of lymphadenectomy in endometrioid endometrial cancer.
Cusidó M, Fargas F, Rodríguez I, Alsina A, Baulies S, Tresserra F, Pascual Martínez A, Ibiza JF, Xaudaró RF.
Eur J Gynaecol Oncol. 2011;32(1):49-53. Erratum in: Eur J Gynaecol Oncol. 2011;32(3):252. Martínez, A [corrected to Pascual Martínez, A].
Cancer in pregnancy: maternal and fetal implications on decision-making.
Gambino A, Gorio A, Carrara L, Agoni L, Franzini R, Lupi GP, Maggino T, Romagnolo C, Sartori E, Pecorelli S.
Eur J Gynaecol Oncol. 2011;32(1):40-5.
Is postoperative CA125 level in patients with epithelial ovarian cancer reliable to guess the optimality of surgery?
Ghaemmaghami F, Akhavan S.
Eur J Gynaecol Oncol. 2011;32(2):192-5.
Multivariate analysis by Cox proportional hazard model on prognosis of patient with epithelial ovarian cancer.
Wang M, He Y, Shi L, Shi C.
Eur J Gynaecol Oncol. 2011;32(2):171-7.
The chemosensitivity of nodal metastases in recurrent epithelial ovarian cancer.
Kataoka F, Tsuda H, Nomura H, Chiyoda T, Tominaga E, Suzuki A, Susumu N, Aoki D.
Eur J Gynaecol Oncol. 2011;32(2):160-3.
Long-term topotecan therapy in recurrent or persistent ovarian cancer.
Cormio G, Loizzi V, Gissi F, Camporeale A, De Mitri P, Leone L, Putignano G, Selvaggi L.
Eur J Gynaecol Oncol. 2011;32(2):153-5.
Rare case of an ovarian monodermal teratoma with functional stroma and extensive ovarian decidualization in a 74-year-old woman.
Vouza E, Dastamani C, Iavazzo C, Bakalianou K, Hasiakos D, Kondi-Pafiti A.
Eur J Gynaecol Oncol. 2011;32(2):243-5.
Ovarian carcinoma presenting with axillary lymph node metastasis: a case report.
Ceccarelli F, Barberi S, Pontesilli A, Zancla S, Ranieri E.
Eur J Gynaecol Oncol. 2011;32(2):237-9.
A case of bilateral ovarian synchronous tumors (left ovarian serous papillary adenocarcinoma and right ovarian malignant mixed Müllerian tumor).
Song MJ, Lee CW, Seo KJ, Kim JA, Park JS, Hur SY.
Eur J Gynaecol Oncol. 2011;32(2):234-6.
Diffuse intraabdominal fibrosis and inflammation mimicking peritoneal carcinomatosis recurred after surgery for borderline ovarian tumor misdiagnosed by 18F-fluorodeoxyglucose-positron emission tomography.
Hong JH, Song SH, Kim SE, Lee JK, Lee NW, Lee KW.
Eur J Gynaecol Oncol. 2011;32(2):231-3.
Aggressive ovarian psammocarcinoma: a case report.
Zakkouri FA, Berrada N, Kettani F, Mrabti H, Jalil A, Errihani H.
Eur J Gynaecol Oncol. 2011;32(2):214-5.
Peptide YY producing strumal carcinoid tumor of the ovary.
Matsunami K, Takagi H, Ichigo S, Murase T, Ikeda T, Imai A.
Eur J Gynaecol Oncol. 2011;32(2):201-2.
Association of CYP1B1 gene polymorphisms and the positive expression of estrogen alpha and estrogen beta with endometrial cancer risk.
Zhu ZY, Mu YQ, Fu XM, Li SM, Zhao FX.
Eur J Gynaecol Oncol. 2011;32(2):188-91.
Malignant changes in adenomyosis in patients with endometrioid adenocarcinoma.
Kucera E, Hejda V, Dankovcik R, Valha P, Dudas M, Feyereisl J.
Eur J Gynaecol Oncol. 2011;32(2):182-4.
Efficiency of postoperative pain management after gynecologic oncological surgeries with the use of morphine + acetaminophen + ketoprofen versus morphine + metamizol + ketoprofen.
Samulak D, Michalska M, Gaca M, Wilczak M, Mojs E, Chuchracki M.
Eur J Gynaecol Oncol. 2011;32(2):168-70.
Diagnostic test for ovarian cancer composed of ovarian cancer symptom index, menopausal status and ovarian cancer antigen CA125.
Macuks R, Baidekalna I, Donina S.
Eur J Gynaecol Oncol. 2011;32(3):286-8.
A prospective randomised phase II trial of thalidomide with carboplatin compared with carboplatin alone as a first-line therapy in women with ovarian cancer, with evaluation of potential surrogate markers of angiogenesis.
Muthuramalingam SR, Braybrooke JP, Blann AD, Madhusudan S, Wilner S, Jenkins A, Han C, Kaur K, Perren T, Ganesan TS.
Eur J Gynaecol Oncol. 2011;32(3):253-8.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on